Impact of Infectious Disease specialist on antifungal agent use

Impact of Infectious Disease specialist on antifungal agent use - Impact of Infectious Disease specialist on antifungal agent use

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020232

Enrollment

80000

Registered

2015-12-17

Start date

2015-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fungal infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: all inpatients in the Showa General Hospital during 2006 to 2016

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
AUD (/1000 patient-day) of intravenous antifungal agents	—

Secondary

Measure	Time frame
spending on antifungal agents	—

Countries

Japan

Contacts

Public ContactDaiichi Morii

the Showa General Hospital Department of Infectious Disease

morrydaich@hotmail.com042-461-0052

Outcome results